OKYO Pharma

OKYO Pharma Ltd is a preclinical biopharmaceutical company developing next-generation therapies to improve the lives of patients suffering from inflammatory eye diseases and ocular pain. We are currently developing OK-101, our lead preclinical candidate product for the treatment of dry eye disease.